Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $4.3 million.

  • Select Medical Holdings' Share-based Compensation fell 6818.93% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.4 million, marking a year-over-year increase of 4340.94%. This contributed to the annual value of $100.7 million for FY2024, which is 12979.3% up from last year.
  • Select Medical Holdings' Share-based Compensation amounted to $4.3 million in Q3 2025, which was down 6818.93% from $4.0 million recorded in Q2 2025.
  • Select Medical Holdings' Share-based Compensation's 5-year high stood at $61.3 million during Q4 2024, with a 5-year trough of $3.9 million in Q1 2025.
  • For the 5-year period, Select Medical Holdings' Share-based Compensation averaged around $11.9 million, with its median value being $9.8 million (2022).
  • As far as peak fluctuations go, Select Medical Holdings' Share-based Compensation skyrocketed by 41845.49% in 2024, and later tumbled by 7202.53% in 2025.
  • Quarter analysis of 5 years shows Select Medical Holdings' Share-based Compensation stood at $8.9 million in 2021, then rose by 9.63% to $9.8 million in 2022, then grew by 20.6% to $11.8 million in 2023, then surged by 418.45% to $61.3 million in 2024, then plummeted by 93.06% to $4.3 million in 2025.
  • Its Share-based Compensation stands at $4.3 million for Q3 2025, versus $4.0 million for Q2 2025 and $3.9 million for Q1 2025.